Results 111 to 120 of about 5,827,281 (280)

Validation of a Cellular Imaging‐Based Method as a Potential Biomarker for SPG4 Hereditary Spastic Paraplegia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Hereditary Spastic Paraplegia (HSP) comprises a group of rare genetic diseases characterized by length‐dependent axonal degeneration of the corticospinal tracts and dorsal columns, whose main clinical feature is spastic gait. Pathogenic variants in the SPG4 gene cause Spastic Paraplegia Type 4 (SPG4‐HSP), the most common form of HSP.
Gaia Fattorini   +12 more
wiley   +1 more source

Clinical experiences with robotic computed tomography-guided interventions: A comparison with manual technique

open access: yesAsian Journal of Medical Sciences
Background: Image-guided biopsies have become standard practice; however, challenges such as multiple punctures and re-attempts can complicate procedures.
Ashwin Kumar A   +2 more
doaj   +1 more source

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang   +10 more
wiley   +1 more source

Effective Dose to Dose-Length Product Coefficients for Calculation of CT Effective Dose [PDF]

open access: yesRadiology, 2009
Razvan C. Opreanu   +2 more
openaire   +1 more source

Symbolic Regression and Multi‐Objective Optimization of the Flory–Huggins Interaction Parameter for Hydrogels

open access: yesAdvanced Engineering Materials, EarlyView.
We develop a data‐driven method to derive the mathematical expressions of the Flory–Huggins interaction parameter χ for the swelling behavior of temperature–responsive hydrogels. Starting from initial assumptions of χ, our workflow combines Bayesian optimization, Flory–Rehner theory, and symbolic regression to generate candidate χ expressions.
Yawen Wang   +2 more
wiley   +1 more source

Product-process interface for effective product design and manufacturing in a DFM approach [PDF]

open access: yes, 2009
This research work is partly supported by SNECMA enterprise. It makes part of the MAIA 8 projectIn order to tackle a continuous improvement of virtual engineering, product modelling has to integrate always more knowledge that refer to every decision ...
El Gueder, Jawhar   +4 more
core  

Establishment of local diagnostic reference levels for CT colonography at a tertiary hospital

open access: yesSouth African Journal of Radiology
Background: Diagnostic reference levels (DRLs) are an important metric in identifying abnormally high radiation doses in diagnostic examinations. National DRLs for CT colonography do not currently exist in South Africa, but there are efforts to collect ...
Filip M. Kozłowski   +2 more
doaj   +1 more source

Prior scanning Estimation of Dose Length Product for Chest Computed Tomography using machine learning

open access: yes
Published via ChairConf (https://chairconf.com) — A Nexus Academia platform (https://nexus-academia.com)
OU HADDA, Hassan   +3 more
openaire   +2 more sources

Optimization of the Production of Rubber Compounds Using Mathematical Models

open access: yesAdvanced Engineering Materials, EarlyView.
Rubber compounds were mixed in a batch internal mixer, and symbolic regression was used to derive mathematical models linking recipe and process parameters to ram path, torque, and mixing quality (incorporation, dispersion, distribution). Subsequent optimization with evolutionary algorithms identified operating conditions that reduce specific energy ...
Anke Bardehle   +7 more
wiley   +1 more source

Practical considerations for optimal designs in clinical dose finding studies [PDF]

open access: yes
Determining an adequate dose level for a drug and, more broadly, characterizing its dose response relationship, are key objectives in the clinical development of any medicinal drug. If the dose is set too high, safety and tolerability problems are likely
Dette, Holger   +2 more
core  

Home - About - Disclaimer - Privacy